Mouse anti-Human sTREM-1 Monoclonal Antibody | anti-sTREM-1 antibody

sTREM-1, Human, mAb 15G7

Cat. Num. AAA584663

• Reactivity: Human
• Applications: Immuno Assay (IA)
• Synonyms: sTREM-1; Monoclonal Antibody; Human; mAb 15G7; soluble Triggering receptor expressed on myeoloid cells 1; anti-sTREM-1 antibody

• Host: Mouse
• Reactivity: Human
• Clonality: Monoclonal
• Isotype: Mouse IgG1
• Clone Number: 15G7
• Form/Format: 1 ml (100 ug/ml) 0.2 um filtered antibody solution in PBS, containing 0.1% bovine serum albumin and 0.02% sodium azide.; For unit size 0.5 mg or larger: PBS only (concentration< 0.5mg/ml)

• Applicable Applications for anti-sTREM-1 antibody: Immuno Assay (IA)
• Application Notes: For Immuno assays dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.
• Immunogen: sTREM-1
• Preparation and Storage: Product should be stored at 4 degree C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.

Related Product Information for anti-sTREM-1 antibody

Monoclonal antibody 15G7 recognizes human triggering receptor expressed on myeloid cells 1 (TREM-1). TREM-1 is member of a family of cell surface receptors which function as modulators of the inflammatory response in sepsis. TREM-1 is widely expressed on cells of the myeloid lineage and acts as an inflammatory trigger and amplifier after fungal and bacterial contact. Expression is predominantly seen on neutrophils, monocytes, macrophages, microglia, osteoclasts and dendritic cells. The TREM family consist of TREM-1, TREM-2, TREM-3 (mouse) and TREM-like transcript 1&2. They are members of the transmembrane immunoglobulin superfamily. TREM-1 is a 30 kD monomeric protein synthesized as a 234 amino acid (aa) precursor with a signal peptide (16 aa), an extracellular domain (184 aa), a transmembrane domain (29 aa), and a short cytoplasmic domain (5 aa). The ligand of TREM-1is unknown. The engagement of TREMs, after association with the adapter protein DAP12 (DNA activating protein 12) which contains an immunoreceptor tyrosine-based activation motif, triggers a signalling pathway that leads to intracellular calcium mobilization, actin cytoskeleton rearrangement, and activation of several transcription factors. TREM-1 acts in synergy with Toll-like receptor signaling pathways in amplifying the inflammatory response. During infections, receptor expression is modulated and soluble TREM-1 (sTREM-1, 17 kDa) is released. TREM-1 is shed from the membrane of activated phagocytes and can be found as sTREM-1 in tissue and body fluids like plasma and bronchoalveolar lavage fluid (BAL). Some studies suggest that sTREM1 is transcribed from an alternative mRNA. sTrem-1 is unable to transmit a signal but competes for binding with endogenous ligands. Thereby dampen the amplification loop which is activated when the infection is started. sTREM1 levels are possibly a prognostic marker for sepsis. However, some other studies show also elevated levels in non-infectious causes of inflammation (e.g. Crohn disease). At least sTREM-1 in biological fluids often correlates with severity of disease.

References

Haselmayer, P et al. Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses. Immunology, 2006. 119:404 Haselmayer, P et al.TREM-1 ligand expression on platelets enhances neutrophil activation. Blood, 2007 110:1029 Radsak, M et al. Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol. 2007 52040. Derive, M et al. Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol. 2012 188:5585 Palazzo, SJ et al. Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) as a Diagnostic Marker of Saurer, L et al. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity. Journal of Crohn's and Colitis 2012 6:913 Su, L et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis. 2012 12:157.